Fetal immune response to oral pathogens and risk of preterm birth

Kim A Boggess1, Kevin Moss, Phoebus Madianos

  • 1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill 27599-7516, USA. kboggess@med.unc.edu

Insights

Fetal immune responses to oral pathogens, indicated by immunoglobulin M (IgM) antibodies, are linked to preterm birth. The risk is amplified when fetuses also show signs of inflammation.

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Neonatal Research

Background:

  • Preterm birth remains a leading cause of neonatal morbidity and mortality.
  • The role of fetal inflammatory and immune responses in the etiology of preterm birth requires further elucidation.

Purpose of the Study:

  • To investigate the association between fetal inflammatory markers and immune responses to oral pathogens and the risk of preterm birth.

Main Methods:

  • Prospective collection of 640 umbilical cord blood samples.
  • Measurement of inflammatory mediators (C-reactive protein, IL-1beta, IL-6, TNF-alpha, Prostaglandin E2, 8-isoprostane) and fetal IgM antibodies to oral pathogens.
  • Statistical analysis to determine the relationship between these markers and spontaneous preterm birth (<35 weeks).

Main Results:

  • Preterm birth rates were significantly higher in cases with elevated 8-isoprostane or TNF-alpha levels, and with positive fetal IgM response to oral pathogens.
  • Combined fetal IgM seropositivity with elevated C-reactive protein, 8-isoprostane, Prostaglandin E2, or TNF-alpha significantly increased the adjusted odds ratio for preterm birth.

Conclusions:

  • Fetal exposure to oral pathogens, evidenced by an IgM response, is associated with an increased risk of preterm birth.
  • The risk is substantially elevated when fetal inflammation is also present, highlighting a dual immune and inflammatory pathway.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...